Metraipolis › archive › dc_2a4d9dc3d796

Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895 — Europe PMC PMID:40844833

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40844833
DOI
10.1158/2767-9764.crc-25-0265
License (as archived)
solo-consultazione
Archived
2026-11-10T05:02:48.077Z
SHA-256 of the archived text
c44662c64bf0e06ce61c7021683a87ef1a2404f3ca138a92bf366684bd1e76e3
Stable URL of this page
https://metraipolis.com/documento/dc_2a4d9dc3d796

How to cite

Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895 — Europe PMC PMID:40844833 — Europe PMC (en), https://europepmc.org/article/MED/40844833 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a4d9dc3d796 (Metraipolis archive dc_2a4d9dc3d796, sha256 c44662c64bf0e06ce61c7021683a87ef1a2404f3ca138a92bf366684bd1e76e3)
BibTeX
@misc{dc2a4d9dc3d796,
  title = {Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895 — Europe PMC PMID:40844833},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40844833},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a4d9dc3d796; sha256 c44662c64bf0e06ce61c7021683a87ef1a2404f3ca138a92bf366684bd1e76e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40844833. Agents can read the archived copy with the MCP tool read_document.